Event Details |
| Amplifying Standard or Metronomic Chemotherapy Efficacy using Antiangiogenic VEGF Pathway Targeting Drugs |
| Date(s): |
|
| Monday, June 09, 2008 |
| |
|
| Time: |
|
| 2:30:00 PM - 3:45:00 PM |
| |
|
| Location: |
|
| Frederick : Bldg 549 Auditorium |
| |
|
| Type of Event: |
| seminar |
| |
|
| Speaker(s)/Group: |
| Robert W. Kerbel, PhD |
| |
|
| Affiliation: |
| University of Toronto |
| |
|
| Directions: |
|
http://web.ncifcrf.gov/about/directions.asp
|
| |
|
| Sponsor: |
| Mouse Cancer Genetics Program |
| |
|
| Contact Information |
| Contact Name: Nicole Moore |
| Phone: 301-846-6680 |
| Email: mooren3@mail.nih.gov |
|
 |
June 2008 |
 |
| Sun |
Mon |
Tue |
Wed |
Thu |
Fri |
Sat |
| 1 |
2 |
3 |
4 |
5 |
6 |
7 |
| 8 |
9 |
10 |
11 |
12 |
13 |
14 |
| 15 |
16 |
17 |
18 |
19 |
20 |
21 |
| 22 |
23 |
24 |
25 |
26 |
27 |
28 |
| 29 |
30 |
|
|
|
|
|
This event is part of the Cancer Genetics and Signaling Seminar Series series.
|
